May is National Brain Tumor Awareness Month. Driven by advancement in research, surgical techniques, genetic discoveries, and much more, it has never been a better time to take action on brain tumors. The National Brain Tumor Society (NBTS), an organization whose mission is to unrelentingly invest in, mobilize, and unite our community to discover a […]
As the COVID-19 pandemic continues, many cancer patients are having to make the difficult decision to continue with their current cancer regimen or delay treatments. Cancer patients and physicians must carefully weigh the potential benefit of routine cancer care versus the risk of COVID-19. To help ease these decisions, several peer-reviewed, non-profit cancer care organizations […]
If you have been diagnosed with low-risk prostate cancer, it is likely you know about active surveillance, a passive form of treatment that started to grow in popularity in 2010. By 2015, 42.1% of low-risk prostate cancer patients opted for getting regular PSA tests, biopsies, and imaging tests instead of a more aggressive treatment plan. […]
Watch and listen to CyberKnife patient, Shawn, and board-certified radiation oncologist and St. Louis CyberKnife Medical Director, John Bedwinek, M.D., talk about how the CyberKnife system treats cancer.
Our very own board-certified radiation oncologist John Bedwinek M.D. was a guest on KSDK TV’s Show Me St. Louis. Dr. Bedwinek discussed prostate cancer (risk factors, symptoms, stats) and the benefits of treating it with the CyberKnife® Robotic Radiosurgery System.
Vernon Traxler suffered from painful trigeminal neuralgia for over 16 years before he found relief with CyberKnife. Watch Vernon explain what those years felt like and how he feels now after being treated at St. Louis CyberKnife.
Accuray Incorporated, developer and manufacturer of the CyberKnife® System, announced that published data from two multicenter studies using differing protocols provide consistent results and reinforce the use of the CyberKnife system for the effective management of low-and intermediate-risk prostate cancer. The studies are the largest conducted to date evaluating stereotactic body radiation therapy (SBRT) in […]
When deciding which treatment option is best for their prostate cancer, men take numerous factors into consideration. While their physician’s recommendation does play an important role in the treatment decision, in the end, most men make the choice that is best for them. That choice is often based on treatment outcomes and side effects, and […]
When it comes to fighting cancer, it takes a team of people. Treatment at our center means that you are not alone in the fight. Cancer treatments are rapidly advancing and having a research focused team of radiation oncologists enables us to bring you the most up-to-date approaches to fighting your specific cancer. In cancer […]